Evidence map›Paper›PMID 29605816›Full record

ArticleJournal of lipid research2018

Regulation of kynurenine metabolism by a ketogenic diet.

Svenja Heischmann, Lindsey B Gano, Kevin Quinn, Li-Ping Liang, Jacek Klepacki, Uwe Christians, Nichole Reisdorph, Manisha Patel

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Psychotomimetic compensation versus sensitization.Pharmacology research & perspectives · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Svenja HeischmannDepartment of Pharmaceutical Sciences, School of Pharmacy University of Colorado Denver, Aurora, CO 80045.
Lindsey B GanoDepartment of Pharmaceutical Sciences, School of Pharmacy University of Colorado Denver, Aurora, CO 80045.
Kevin QuinnDepartment of Pharmaceutical Sciences, School of Pharmacy University of Colorado Denver, Aurora, CO 80045.
Li-Ping LiangDepartment of Pharmaceutical Sciences, School of Pharmacy University of Colorado Denver, Aurora, CO 80045.
Jacek KlepackiiC42 Clinical Research and Development, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO 80045.
Uwe ChristiansiC42 Clinical Research and Development, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO 80045.
Nichole ReisdorphDepartment of Pharmaceutical Sciences, School of Pharmacy University of Colorado Denver, Aurora, CO 80045.
Manisha PatelDepartment of Pharmaceutical Sciences, School of Pharmacy University of Colorado Denver, Aurora, CO 80045. Electronic address: Manisha.Patel@ucdenver.edu.
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · US

Funding

SUPEROXIDE RADICALS IN SEIZURE-INDUCED NEURONAL DEATHR01NS039587 · NINDS · UNIVERSITY OF COLORADO DENVER · PI PATEL, MANISHA N · 2000 to 2019
$5.9M
Redox Control of Seizure-Induced Neuroinflammation.R01NS086423 · NINDS · UNIVERSITY OF COLORADO DENVER · PI PATEL, MANISHA N · 2013 to 2022
$3.0M
Mitochondrial Mechanisms of Astrogliosis in EpilesyR37NS039587 · NINDS · UNIVERSITY OF COLORADO DENVER · PI MANISHA N PATEL · 2022 to 2026
$2.8M
Sirtuin 3 Dysregulation in EpileptogenesisF32NS090808 · NINDS · UNIVERSITY OF COLORADO DENVER · PI GANO, LINDSEY BROOKE · 2015 to 2015
$53k
NINDS NIH HHS F32 NS090808NINDS NIH HHS R01 NS039587NINDS NIH HHS R01 NS086423NINDS NIH HHS R37 NS039587
6 · The paper itself

Abstract

Ketogenic diets (KDs) are increasingly utilized as treatments for epilepsy, other neurological diseases, and cancer. Despite their long history in suppressing seizures, the distinct molecular mechanisms of action of KDs are still largely unknown. The goal of this study was to identify key metabolites and pathways altered in the hippocampus and plasma of rats fed a KD versus control diet (CD) either ad libitum or calorically restricted to 90% of the recommended intake. This was accomplished using a combination of targeted methods and untargeted MS-based metabolomics analyses. Various metabolites of and related to the tryptophan (TRP) degradation pathway, such as kynurenine (KYN), kynurenic acid as well as enzyme cofactors, showed significant changes between groups fed different diets and/or calorie amounts in plasma and/or the hippocampus. KYN was significantly downregulated in both matrices in animals of the CD-calorically restricted, KD-ad libitum, and KD-calorically restricted groups compared with the CD-ad libitum group. Our data suggest that the TRP degradation pathway is a key target of the KD.

Indexed as

Diet, KetogenicAnimalsKynurenineMaleRatsRats, Sprague-DawleyKynureninebraincaloric restrictiondiet effects/lipid metabolismepilepsykynurenic acidkynurenine pathwaymass spectrometrymetabolomicsnutritiontryptophan

Identifiers

PMID29605816
PMCPMC5983405
OpenAlexW2795108631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.